Retrospective Study of the Significant Predictive Role of Inflammatory Degree in Initial and Repeat Prostate Biopsy Specimens for Detecting Prostate Cancer
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose The purpose of this study was to determine whether histologic inflammation (HI) in initial and repeat prostate biopsy specimens was significantly associated with the detection of prostate cancer. Materials and Methods Between 2005 and 2017, the clinicopathological records of patients with high prostatespecific antigen (PSA) levels who underwent initial and repeat prostate biopsies were retrospectively reviewed. The presence of HI and its degree in each biopsied specimen were interpreted by one uropathologist with 20 years of experience. The association between HI and cancer diagnosis was statistically assessed, with p < 0.05 considered significant, and the cancer and non-cancer groups were compared. Results Among the 522 patients with a median PSA levels of 6.5 ng/dL, including 258 (49.4%) whose cancer was diagnosed following repeat biopsy, the median degrees of HI in the initial and repeat biopsies were 25.0% and 41.7%, respectively. Furthermore, 211 (40.4%) and 247 (47.3%) patients had HI (> 0%) on biopsied specimens, respectively. Comparison of the cancer and noncancer groups revealed that a greater rate of HI specimens in the initial biopsy was associated with fewer prostate cancer diagnoses following repeat biopsy (p < 0.001). Other comparisons between the cancer and non-cancer groups showed that the cancer group had a significantly higher rate of hypertension, whereas those non-cancer group had a significantly higher rate of benign prostatic hyperplasia and prostatitis (p < 0.05). Conclusion A finding of a lesser degree of HI in the initial and a greater degree of HI in the repeat biopsied specimens was associated with the higher probability of cancer diagnosis in patients with high PSA levels.
Abstract
Purpose The purpose of this study was to determine whether histologic inflammation (HI) in initial and repeat prostate biopsy specimens was significantly associated with the detection of prostate cancer. Materials and Methods Between 2005 and 2017, the clinicopathological records of patients with high prostatespecific antigen (PSA) levels who underwent initial and repeat prostate biopsies were retrospectively reviewed. The presence of HI and its degree in each biopsied specimen were interpreted by one uropathologist with 20 years of experience. The association between HI and cancer diagnosis was statistically assessed, with p < 0.05 considered significant, and the cancer and non-cancer groups were compared. Results Among the 522 patients with a median PSA levels of 6.5 ng/dL, including 258 (49.4%) whose cancer was diagnosed following repeat biopsy, the median degrees of HI in the initial and repeat biopsies were 25.0% and 41.7%, respectively. Furthermore, 211 (40.4%) and 247 (47.3%) patients had HI (> 0%) on biopsied specimens, respectively. Comparison of the cancer and noncancer groups revealed that a greater rate of HI specimens in the initial biopsy was associated with fewer prostate cancer diagnoses following repeat biopsy (p < 0.001). Other comparisons between the cancer and non-cancer groups showed that the cancer group had a significantly higher rate of hypertension, whereas those non-cancer group had a significantly higher rate of benign prostatic hyperplasia and prostatitis (p < 0.05). Conclusion A finding of a lesser degree of HI in the initial and a greater degree of HI in the repeat biopsied specimens was associated with the higher probability of cancer diagnosis in patients with high PSA levels.
참고문헌 (23)
- Constantinou J, "PSA testing : an evolving relationship with prostate cancer screening", Prostate Cancer Prostatic Dis, 9, pp.6~13 (2006)
- Blute ML Jr, "Addressing the need for repeat prostate biopsy : new technology and approaches", Nat Rev Urol, 12, pp.435~444 (2015)
- Mohammed AA, "Biomarkers in prostate cancer : new era and prospective", Med Oncol, 31, pp.140~ (2014)
- Yli-Hemminki TH, "Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen(PSA)concentration in the Finnish prostate cancer screening trial", BJU Int, 112, pp.735~741 (2013)
- De Marzo AM, "Inflammation in prostate carcinogenesis", Nat Rev Cancer, 7, pp.256~269 (2007)
- Mahmud S, "Prostate cancer and use of nonsteroidal anti-inflammatory drugs : systematic review and meta-analysis", Br J Cancer, 90, pp.93~99 (2004)
- De Marzo AM, "Proliferative inflammatory atrophy of the prostate : implications for prostatic carcinogenesis", Am J Pathol, 155, pp.1985~1992 (1999)
- Amara S, "Inflammatory role of high salt level in tumor microenvironment(review)", Int J Oncol, 50, pp.1477~1481 (2017)
- Liu S, "Propofol attenuates intermittent hypoxia induced up-regulation of proinflammatory cytokines in microglia through inhibiting the activation of NF-Bkappa", p38 MAPK signalling, 2017, pp.55, 124~131
- Fassi Fehri L, "Prevalence of Propionibacterium acnes in diseased prostates and its inflammatory and transforming activity on prostate epithelial cells", Int J Med Microbiol, 301, pp.69~78 (2011)
- T. R. Huang, "Differential research of inflammatory and related mediators in BPH, histological prostatitis and PCa", Andrologia, 50(4), pp.e12974~ (2018), Wiley[DOI]
- Romagny S, "S-Nitrosylation of cIAP1 switches cancer cell fate from TNFalpha", TNFR1-mediated cell survival to cell death, 2018, pp.78, 1948~1957
- Billis A, "Prostatic atrophy : clinicopathological significance", Int Braz J Urol, 36, pp.401~409 (2010)
- Vasavada SR, "Inflammation on prostate needle biopsy is associated with lower prostate cancer risk : a meta-analysis", J Urol, 199, pp.1174~1181 (2018)
- Busby JE, "Determining variables for repeat prostate biopsy", Prostate Cancer Prostatic Dis, 7, pp.93~98 (2004)
- Scattoni V, "Random biopsy: when, how many and where to take the cores?", World J Urol, 32, pp.859~869 (2014)
- Ukimura O, "Contemporary role of systematic prostate biopsies : indications, techniques, and implications for patient care", Eur Urol, 63, pp.214~230 (2013)
- Futterer JJ, "Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature", Eur Urol, 68, pp.1045~1053 (2015)
- Mortezavi A, "Diagnostic accuracy of multiparametric magnetic resonance imaging and fusion guided targeted biopsy evaluated by transperineal template saturation prostate biopsy for the detection and characterization of prostate cancer", J Urol, 200, pp.309~318 (2018)
- Djavan B, "Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies : results of a prospective European prostate cancer detection study", J Urol, 166, pp.856~860 (2001)
- Rosenkrantz AB, "Radiologist, be aware : ten pitfalls that confound the interpretation of multiparametric prostate MRI", AJR Am J Roentgenol, 202, pp.109~120 (2014)
- Pal RP, "A single center evaluation of the diagnostic accuracy of multiparametric magnetic resonance imaging against transperineal prostate mapping biopsy : an analysis of men with benign histology and insignificant cancer following transrectal ultrasound biopsy", J Urol, 200, pp.302~308 (2018)
- Schouten MG, "Why and where do we miss significant prostate cancer with multi-parametric magnetic resonance imaging followed by magnetic resonance-guided and transrectal ultrasound-guided biopsy in biopsy-naive men?", Eur Urol, 71, pp.896~903 (2017)